Parker Institute for Cancer Immunotherapy
@parkerici
Our mission is to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases
25-02-2016 19:43:35
3,8K Tweets
10,8K Followers
682 Following
PICI-supported nature study: 2022 Parker Bridge Fellow Evan Weber & Penn Medicine, Children's Hospital Stanford Medicine program CAR T cells w/ high FOXO1. Gives stem-cell properties, faster growth & longer survival. Could improve CAR T efficacy across cancers. nature.com/articles/s4158…